Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Gafchromic films support patient care in oncology
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
Subscribe To Our Newsletter & Stay Updated
